Management of coagulation abnormalities in liver disease.

about

Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.

P2860

Q45871338-1640F1FE-E817-4C74-88A1-44E9282F0F5F

P2860

Management of coagulation abnormalities in liver disease.

Item

http://www.wikidata.org/entity/Q38223728

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Management of coagulation abnormalities in liver disease.

@en

type

Item

label

Management of coagulation abnormalities in liver disease.

@en

prefLabel

Management of coagulation abnormalities in liver disease.

@en

P1476

Management of coagulation abnormalities in liver disease

@en

P2093

Robert J Porte

http://www.w3.org/2001/XMLSchema#string

Wilma Potze

http://www.w3.org/2001/XMLSchema#string

P2860

Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis

Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.

Coagulation in liver disease: a guide for the clinician.

Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding.

Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation.

A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.

Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease.

Hypercoagulability in cirrhosis: causes and consequences.

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.

P304

103-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2014.934673

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ton Lisman

P577

2014-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24970667

http://www.w3.org/2001/XMLSchema#string

Management of coagulation abnormalities in liver disease.

about

P2860

P2860

Management of coagulation abnormalities in liver disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698